- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06846515
Fase 3-evaluering af effektivitet og sikkerhed for AR882 hos gigtpatienter (AR882-301)
En fase 3 randomiseret, dobbeltblind, multicenter, placebo-kontrolleret undersøgelse for at evaluere effektiviteten og sikkerheden for AR882 hos deltagere med gigt
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35215
- Arthrosi Investigative Site (620)
-
Huntsville, Alabama, Forenede Stater, 35801
- Arthrosi Investigative Site (616)
-
-
Arizona
-
Peoria, Arizona, Forenede Stater, 85381
- Arthrosi Investigative Site (680)
-
Phoenix, Arizona, Forenede Stater, 85018
- Arthrosi Investigative Site (640)
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72205
- Arthrosi Investigative Site (617)
-
-
California
-
Garden Grove, California, Forenede Stater, 92844
- Arthrosi Investigative Site (614)
-
La Mesa, California, Forenede Stater, 91942
- Arthrosi Investigative Site (618)
-
La Mesa, California, Forenede Stater, 91942
- Arthrosi Investigative Site (687)
-
La Palma, California, Forenede Stater, 90623
- Arthrosi Investigative Site (655)
-
Lincoln, California, Forenede Stater, 95648
- Arthrosi Investigative Site (632)
-
Lomita, California, Forenede Stater, 90717
- Arthrosi Investigative Site (605)
-
Long Beach, California, Forenede Stater, 90806
- Arthrosi Investigative Site (675)
-
Santa Monica, California, Forenede Stater, 90404
- Arthrosi Investigative Site (603)
-
Tarzana, California, Forenede Stater, 91356
- Arthrosi Investigative Site (672)
-
Thousand Oaks, California, Forenede Stater, 91360
- Arthrosi Investigative Site (656)
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80012
- Arthrosi Investigative Site (660)
-
Colorado Springs, Colorado, Forenede Stater, 80909
- Arthrosi Investigative Site (669)
-
Fort Collins, Colorado, Forenede Stater, 80528
- Arthrosi Investigative Site (612)
-
-
Florida
-
Cooper City, Florida, Forenede Stater, 33024
- Arthrosi Investigative Site (665)
-
Jupiter, Florida, Forenede Stater, 33458
- Arthrosi Investigative Site (613)
-
Miami, Florida, Forenede Stater, 33173
- Arthrosi Investigative Site (611)
-
Miami, Florida, Forenede Stater, 33176
- Arthrosi Investigative Site (644)
-
Palmetto Bay, Florida, Forenede Stater, 33157
- Arthrosi Investigative Site (694)
-
Sanford, Florida, Forenede Stater, 32771
- Arthrosi Investigative Site (615)
-
Tampa, Florida, Forenede Stater, 33609
- Arthrosi Investigative Site (600)
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30329
- Arthrosi Investigative Site (673)
-
Marietta, Georgia, Forenede Stater, 30060
- Arthrosi Investigative Site (652)
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96814
- Arthrosi Investigative Site (658)
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83713
- Arthrosi Investigative Site (676)
-
Meridian, Idaho, Forenede Stater, 83642
- Arthrosi Investigative Site (634)
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60602
- Arthrosi Investigative Site (657)
-
Melrose Park, Illinois, Forenede Stater, 60160
- Arthrosi Investigative Site (648)
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202
- Arthrosi Investigative Site (678)
-
-
Kansas
-
Overland Park, Kansas, Forenede Stater, 66209
- Arthrosi Investigative Site (679)
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40205
- Arthrosi Investigative Site (674)
-
-
Louisiana
-
Mandeville, Louisiana, Forenede Stater, 70471
- Arthrosi Investigative Site (627)
-
New Orleans, Louisiana, Forenede Stater, 70115
- Arthrosi Investigative Site (650)
-
Prairieville, Louisiana, Forenede Stater, 70769
- Arthrosi Investigative Site (641)
-
-
Maryland
-
Oxon Hill, Maryland, Forenede Stater, 20745
- Arthrosi Investigative Site (662)
-
Rockville, Maryland, Forenede Stater, 20852
- Arthrosi Investigative Site (653)
-
-
Massachusetts
-
Fall River, Massachusetts, Forenede Stater, 02721
- Arthrosi Investigative Site (636)
-
-
Michigan
-
Farmington Hills, Michigan, Forenede Stater, 48334
- Arthrosi Investigative Site (628)
-
Southfield, Michigan, Forenede Stater, 48076
- Arthrosi Investigative Site (645)
-
-
Mississippi
-
Gulfport, Mississippi, Forenede Stater, 39503
- Arthrosi Investigative Site (633)
-
Jackson, Mississippi, Forenede Stater, 39202
- Arthrosi Investigative Site (635)
-
Olive Branch, Mississippi, Forenede Stater, 38654
- Arthrosi Investigative Site (693)
-
-
Missouri
-
Springfield, Missouri, Forenede Stater, 65807
- Arthrosi Investigative Site (637)
-
Town and Country, Missouri, Forenede Stater, 63017
- Arthrosi Investigative Site (626)
-
-
Montana
-
Missoula, Montana, Forenede Stater, 59808
- Arthrosi Investigative Site (664)
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68516
- Arthrosi Investigative Site (610)
-
Omaha, Nebraska, Forenede Stater, 68114
- Arthrosi Investigative Site (684)
-
Omaha, Nebraska, Forenede Stater, 68144
- Arthrosi Investigative Site (651)
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89102
- Arthrosi Investigative Site (686)
-
-
New York
-
Brooklyn, New York, Forenede Stater, 11215
- Arthrosi Investigative Site (661)
-
Hartsdale, New York, Forenede Stater, 10530
- Arthrosi Investigative Site (663)
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28207
- Arthrosi Investigative Site (625)
-
Charlotte, North Carolina, Forenede Stater, 28277
- Arthrosi Investigative Site (681)
-
Raleigh, North Carolina, Forenede Stater, 27607
- Arthrosi Investigative Site (683)
-
Shelby, North Carolina, Forenede Stater, 28150
- Arthrosi Investigative Site (649)
-
-
North Dakota
-
Fargo, North Dakota, Forenede Stater, 58104
- Arthrosi Investigative Site (666)
-
-
Ohio
-
Mason, Ohio, Forenede Stater, 45040
- Arthrosi Investigative Site (671)
-
-
Oklahoma
-
Norman, Oklahoma, Forenede Stater, 73072
- Arthrosi Investigative Site (631)
-
Tulsa, Oklahoma, Forenede Stater, 74133
- Arthrosi Investigative Site (642)
-
-
Pennsylvania
-
Horsham, Pennsylvania, Forenede Stater, 19044
- Arthrosi Investigative Site (647)
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Arthrosi Investigative Site (623)
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29407
- Arthrosi Investigative Site (638)
-
Fort Mill, South Carolina, Forenede Stater, 29707
- Arthrosi Investigative Site (604)
-
North Charleston, South Carolina, Forenede Stater, 29405
- Arthrosi Investigative Site (608)
-
-
Tennessee
-
Chattanooga, Tennessee, Forenede Stater, 37404
- Arthrosi Investigative Site (619)
-
Hendersonville, Tennessee, Forenede Stater, 37075
- Arthrosi Investigative Site (624)
-
-
Texas
-
Amarillo, Texas, Forenede Stater, 79106
- Arthrosi Investigative Site (670)
-
Austin, Texas, Forenede Stater, 78735
- Arthrosi Investigative Site (677)
-
DeSoto, Texas, Forenede Stater, 75115
- Arthrosi Investigative Site (639)
-
Houston, Texas, Forenede Stater, 77074
- Arthrosi Investigative Site (601)
-
Plano, Texas, Forenede Stater, 75024
- Arthrosi Investigative Site (688)
-
Prosper, Texas, Forenede Stater, 75078
- Arthrosi Investigative Site (689)
-
Tomball, Texas, Forenede Stater, 77375
- Arthrosi Investigative Site (646)
-
Tomball, Texas, Forenede Stater, 77375
- Arthrosi Investigative Site (659)
-
-
Utah
-
Clinton, Utah, Forenede Stater, 84015
- Arthrosi Investigative Site (643)
-
Salt Lake City, Utah, Forenede Stater, 84121
- Arthrosi Investigative Site (609)
-
Salt Lake City, Utah, Forenede Stater, 84124
- Arthrosi Investigative Site (654)
-
-
Washington
-
Bellevue, Washington, Forenede Stater, 98004
- Arthrosi Investigative Site (685)
-
-
Wisconsin
-
Kenosha, Wisconsin, Forenede Stater, 53144
- Arthrosi Investigative Site (668)
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- History of gout
- Occurrence of ≥ 2 self-reported gout flares in the last 12 months
- Body weight no less than 50 kg
- Patients who are NOT on approved urate-lowering therapy (ULT) must have sUA ≥ 7 mg/dL
- Patients who are on medically appropriate ULT must have sUA > 6 mg/dL
- Serum creatinine must be < 3.0 mg/dL and estimated CLcr ≥ 30 mL/min
Exclusion Criteria:
- Malignancy within 5 years, except for successfully treated basal or squamous cell carcinoma of the skin
- Pregnant or breastfeeding
- History of symptomatic kidney stones within the past 6 months
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: AR882 50 mg
AR882 50 mg taken once daily for 12 months |
Solid Oral Capsule |
|
Eksperimentel: AR882 75 mg
AR882 75 mg taken once daily for 12 months |
Solid Oral Capsule |
|
Placebo komparator: Placebo
AR882 matching placebo taken once daily for 12 months |
Matching Solid Oral Capsule Placebo |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6
Tidsramme: 24 weeks
|
Comparison of the treatment groups for the proportion of patients with serum urate (uric acid) (sUA) level < 6 mg/dL at month 6 |
24 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in tophus burden by month 12
Tidsramme: 48 weeks
|
Comparison of the treatment groups for the proportion of patients who experience a complete response, marked or partial response, of at least 1 target tophus at Month 12, with no evidence of disease progression (no new tophus or single tophus showing progression) and patients with no new tophi formation at month 12 as determined using the computer-assisted photographic evaluation in rheumatology (CAPER) method |
48 weeks
|
|
Serum urate (uric acid) (sUA) level < 6 mg/dL from the end of month 9 to the end of month 12
Tidsramme: 12 weeks
|
Comparison of the treatment groups for the proportion of patients with serum urate (uric acid) (sUA) level < 6 mg/dL for the 3-month period from the end of month 9 to the end of month 12 |
12 weeks
|
|
Change in tophus burden by month 6
Tidsramme: 24 weeks
|
Comparison of the treatment groups for the proportion of patients who experience a complete response, marked or partial response, of at least 1 target tophus at Month 6, with no evidence of disease progression (no new tophus or single tophus showing progression) and patients with no new tophi formation at month 6 as determined using the computer-assisted photographic evaluation in rheumatology (CAPER) method |
24 weeks
|
|
Incidence of Adverse Events
Tidsramme: 56 weeks
|
Treatment Emergent Adverse Events and Serious Adverse Event incidence |
56 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studieleder: Robert Keenan, MD, Arthrosi Therapeutics, Inc.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Krystalarthropatier
- Muskuloskeletale sygdomme
- Patologiske processer
- Gigt
- Ledsygdomme
- Reumatiske sygdomme
- Purin-Pyrimidin metabolisme, medfødte fejl
- Metabolisme, medfødte fejl
- Genetiske sygdomme, medfødte
- Metaboliske sygdomme
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Ernæringsmæssige og metaboliske sygdomme
- Gigt
- Hyperurikæmi
- Gigt, gigt
Andre undersøgelses-id-numre
- AR882-301
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .